Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people.
Parry H, Bruton R, Ayodele R, Sylla P, McIlroy G, Logan N, Scott S, Nicol S, Verma K, Stephens C, Willett B, Zuo J, Moss P.
Parry H, et al. Among authors: logan n.
Cell Rep Med. 2022 Sep 20;3(9):100739. doi: 10.1016/j.xcrm.2022.100739. Epub 2022 Aug 25.
Cell Rep Med. 2022.
PMID: 36075216
Free PMC article.